https://www.selleckchem.com/pr....oducts/cep-18770.htm
A total of 496 patients (348 pre-policy change; 148 post-policy change) started treatment; excluding loss to follow-up/early discontinuation, SVR rates were 95.4% (309 of 324) pre-policy change and 97.1% (134 of 138) post-policy change. SVR rates did not differ after adjusting for the use of historic HCV regimens and the higher cirrhosis rate in the pre-policy change group compared with the post-policy change group (odds ratio = 0.98; 95% CI, 0.32-3.67). HCV SVR rates were similar before and after removal of the Illinois Medicaid sobr
Gefällt mir
Kommentar
Teilen
